Recombinant O-type foot-and-mouth disease virus epitope gene Seneca recombinant virus, recombinant vaccine and its preparation method and application
A technology of foot-and-mouth disease virus and recombinant virus, applied in the field of genetic engineering, to achieve good reactogenicity, high virus titer, and reduced pathogenicity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0082] The present invention also provides a preparation method of the Seneca recombinant vaccine of the recombinant O-type foot-and-mouth disease virus epitope gene, comprising the following steps:
[0083] 1) Inoculating the Seneca recombinant virus into susceptible cells for proliferation and culture to obtain the Seneca recombinant virus liquid;
[0084] 2) Inactivating and emulsifying the Seneca recombinant virus in the Seneca recombinant virus liquid to obtain the Seneca recombinant vaccine.
[0085] The susceptible cells described in step 1) of the present invention preferably include BHK-21 cells, PK-15 cells, ST cells, SK-RST cells, IBRS-2 cells, H1299 cells or 293T cells, more preferably BHK-21 suspension cells or ST suspension cells.
[0086] In the present invention, when carrying out the proliferation culture described in step 1), the virus titer of the Seneca recombinant virus is preferably not less than 10 6.5 TCID 50 / mL, more preferably 10 6.5 TCID 50 / mL...
Embodiment 1
[0095] Acquisition of B-cell Epitope and T-cell Epitope Genes of Type O Foot-and-Mouth Disease Virus
[0096] According to the gene sequence of the O / BY / 2010 strain (Genebank: JN998085), a flexible Linker (Gly-Gly-Gly- Gly-Ser) in series for three times, and at the 3' end, link the 21-35 amino acid coding gene of FMDV 3A in series, and the 2A gene in series at the same time, to obtain the series O-type FMDV B cell epitope, 3A T cell epitope and 2A Gene, the recombinant epitope gene OB-3A. At the same time, according to the sequence of the SVV / FJ / 001 strain, the gene sequence for synthesizing SVA on the flanks includes the 5' end SphI to the 3' end NheI (NheI is an enzyme cleavage site introduced after undergoing amino acid synonymous mutation according to the sequence of SVA), synthesized The gene containing recombinant O-type foot-and-mouth disease virus epitope gene OB-3A is the nucleotide sequence shown in SEQ ID NO.1.
Embodiment 2
[0098] Construction of Seneca Virus Infectious Clones of Recombinant Type O Foot-and-Mouth Disease Virus Epitope Gene
[0099] The SVV / FJ / 001 strain used is preserved in the China Center for Type Culture Collection (microorganism preservation number: CCTCC NO: V201802), (disclosed in the authorized patent "Seneca Valley virus vaccine and its preparation method and application" ZL201810003888.2 , which is incorporated in this application by reference in its entirety), according to the SVA genome sequence (Genebank: KY747510), design synthetic amplification primers:
[0100] SVA-1F0:
[0101] 5'-gtgaggacgaaactataggaaaggaattcctatagtcttgaaagggggggctgggcc-3' (SEQ ID NO. 3);
[0102] SVA-1F: 5'-ataggtttaattaatgttaagcgtctgatgagtccgtgaggacgaaactatagga-3' (SEQ ID NO. 4)
[0103] SVA-1R: 5'-gggaagcatgctggggcaccaggcac-3' (SEQ ID NO.5)
[0104] SVA-2F1: 5'-gccctgctagcgacaacccgatcctg-3' (SEQ ID NO. 6)
[0105]SVA-2F: 5'-ccccagcatgcttccctttcgcagc-3' (SEQ ID NO.10)
[0106] SVA-2R: 5'-t...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com